Dr. Howard Smith Oncall

Vidcast:  https://www.instagram.com/p/DMYXNKuvaTI/Adolescent vapers taking the drug varenicline, branded as Chantix, were 8 times more likely to abandon the practice compared with those receiving behavioral counseling and a quit-vaping text program.  This the finding from a study by Harvard’s Mass General Hospital psychiatrists studying addiction in young adults.Their trial included 261 adolescents 16 to 25 receiving either the test drug, a placebo drug, or conventional counseling over a 3 month period.   When the data were tabulated, 51% of those on varenicline had completely stopped vaping, compared with 14% in the placebo group, and about 6% receiving counseling.  The effect was lasting with more than half of the Chantix group remaining vape-free 6 months after stopping therapy.With 1.6 million American middle and high school kids vaping in 2024 according to the CDC, an effective medication to help drive vaping cessation is more than welcome.  Chantix is a prescription drug, so parents do speak with your c